Achieve Life Sciences, Inc. (ACHV)
NASDAQ·Healthcare·Biotechnology
$4.27
+7.83%
Mkt Cap $224.65M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$4.75
Range $4.00 – $5.50
Implied Upside
+11.2%
Consensus $4.75 vs current $4.27
NASDAQ·Healthcare·Biotechnology
$4.27
+7.83%
Mkt Cap $224.65M
No recent rating data.
Price Target (2 analysts)
$4.75
Range $4.00 – $5.50
+11.2%
Consensus $4.75 vs current $4.27